Epidemiologic description and therapeutic outcomes of cutaneous leishmaniasis in Childhood in Isfahan, Iran (2011-2016) | Abstract

International Journal of Medical Research & Health Sciences (IJMRHS)
ISSN: 2319-5886 Indexed in: ESCI (Thomson Reuters)


Epidemiologic description and therapeutic outcomes of cutaneous leishmaniasis in Childhood in Isfahan, Iran (2011-2016)

Author(s):Mujtaba Shuja, Javad Ramazanpour, Hasan Ebrahimzade Parikhani, Hamid Salehiniya, Ali Asghar Valipour, Mahdi Mohammadian, Khadijah Allah Bakeshei, Salman Norozi, Mohammad Aryaie, Pezhman Bagheri, Fatemeh Allah Bakeshei, Turan Taghizadeh and Abdollah Mohammadian-Hafshejani

Cutaneous leishmaniasis is a parasitic disease produced by Leishmania parasite and is transmitted by sandfly. The aim of this study was to investigating the epidemiology of Cutaneous leishmaniasis and different aspects of treatment in children with 10 years of age and under in Isfahan Province. This cross-sectional study was conducted on 3143 child cases of cutaneous leishmaniasis in Isfahan province during the March 2011 to March 2016. Descriptive statistics were used to describe demographic and clinical status of cutaneous leishmaniasis in children. The relationship between treatment regime with demographic and clinical variables were examined using Chisquare test. Data of the study was analyzed by using SPSS 18, software. The significance level of the tests was considered as P�?�?��?�??0.05. Of 3143 cases, 52.3% were boys, 51.6% were in rural areas and 91.6 % were Iranian. Leishmania major with 91% of cases was the most common species of the cutaneous leishmaniasis. The relationship between treatment regime and age group , season, year of disease occurrence, Leishmania parasite, residential area, nationality, travel history, travel location and simultaneous disease in other family members were statistically significant as (P<0.05). Children in Isfahan Province are at high risk of disease occurrence. Cutaneous leishmaniasis treatment in Iranian children was consistent with cutaneous leishmaniasis treatment guideline and scientific evidence. However, the process for combating the animal reservoirs and mosquito vector should be considered as a priority to control disease. Furthermore, the facilities should be provided for accurate and timely diagnosis and treatment of patients.

Select your language of interest to view the total content in your interested language

Scope Categories
  • Clinical Research
  • Epidemiology
  • Oncology
  • Biomedicine
  • Dentistry
  • Medical Education
  • Physiotherapy
  • Pulmonology
  • Nephrology
  • Gynaecology
  • Dermatology
  • Dermatoepidemiology
  • Otorhinolaryngology
  • Ophthalmology
  • Sexology
  • Osteology
  • Kinesiology
  • Neuroscience
  • Haematology
  • Psychology
  • Paediatrics
  • Angiology/Vascular Medicine
  • Critical care Medicine
  • Cardiology
  • Endocrinology
  • Gastroenterology
  • Infectious Diseases and Vaccinology
  • Hepatology
  • Geriatric Medicine
  • Bariatrics
  • Pharmacy and Nursing
  • Pharmacognosy and Phytochemistry
  • Radiobiology
  • Pharmacology
  • Toxicology
  • Clinical immunology
  • Clinical and Hospital Pharmacy
  • Cell Biology
  • Genomics and Proteomics
  • Pharmacogenomics
  • Bioinformatics and Biotechnology